RxSight (RXST) Competitors $33.66 -4.53 (-11.86%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends RXST vs. INSP, PRCT, AXNX, NVCR, NVST, NARI, IRTC, LIVN, ENOV, and WRBYShould you be buying RxSight stock or one of its competitors? The main competitors of RxSight include Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), NovoCure (NVCR), Envista (NVST), Inari Medical (NARI), iRhythm Technologies (IRTC), LivaNova (LIVN), Enovis (ENOV), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. RxSight vs. Inspire Medical Systems PROCEPT BioRobotics Axonics NovoCure Envista Inari Medical iRhythm Technologies LivaNova Enovis Warby Parker RxSight (NASDAQ:RXST) and Inspire Medical Systems (NYSE:INSP) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, profitability, institutional ownership, valuation, earnings, dividends, community ranking, analyst recommendations and risk. Does the media prefer RXST or INSP? In the previous week, RxSight had 5 more articles in the media than Inspire Medical Systems. MarketBeat recorded 11 mentions for RxSight and 6 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.40 beat RxSight's score of 0.05 indicating that Inspire Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RxSight 2 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Inspire Medical Systems 5 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, RXST or INSP? RxSight has a beta of 1.11, meaning that its share price is 11% more volatile than the S&P 500. Comparatively, Inspire Medical Systems has a beta of 1.31, meaning that its share price is 31% more volatile than the S&P 500. Do insiders & institutionals have more ownership in RXST or INSP? 78.8% of RxSight shares are held by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are held by institutional investors. 9.4% of RxSight shares are held by company insiders. Comparatively, 4.1% of Inspire Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Does the MarketBeat Community believe in RXST or INSP? Inspire Medical Systems received 141 more outperform votes than RxSight when rated by MarketBeat users. However, 69.70% of users gave RxSight an outperform vote while only 61.31% of users gave Inspire Medical Systems an outperform vote. CompanyUnderperformOutperformRxSightOutperform Votes4669.70% Underperform Votes2030.30% Inspire Medical SystemsOutperform Votes18761.31% Underperform Votes11838.69% Which has preferable earnings and valuation, RXST or INSP? Inspire Medical Systems has higher revenue and earnings than RxSight. RxSight is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRxSight$128.29M10.57-$48.61M-$0.83-40.55Inspire Medical Systems$755.59M7.45-$21.15M$1.07175.49 Is RXST or INSP more profitable? Inspire Medical Systems has a net margin of 4.37% compared to RxSight's net margin of -23.92%. Inspire Medical Systems' return on equity of 5.30% beat RxSight's return on equity.Company Net Margins Return on Equity Return on Assets RxSight-23.92% -14.00% -12.51% Inspire Medical Systems 4.37%5.30%4.58% Do analysts prefer RXST or INSP? RxSight currently has a consensus price target of $59.00, indicating a potential upside of 75.28%. Inspire Medical Systems has a consensus price target of $233.58, indicating a potential upside of 24.40%. Given RxSight's higher possible upside, equities analysts plainly believe RxSight is more favorable than Inspire Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score RxSight 0 Sell rating(s) 2 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.75Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.75 SummaryInspire Medical Systems beats RxSight on 12 of the 17 factors compared between the two stocks. Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Get RxSight News Delivered to You Automatically Sign up to receive the latest news and ratings for RXST and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RXST vs. The Competition Export to ExcelMetricRxSightOphthalmic goods IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.36B$11.10B$5.13B$9.08BDividend YieldN/A0.97%4.91%4.22%P/E Ratio-40.5541.2391.4117.18Price / Sales10.574.441,113.72116.79Price / CashN/A16.6942.7137.86Price / Book7.533.324.794.78Net Income-$48.61M$235.23M$120.07M$225.60M7 Day Performance-9.76%-1.41%-1.92%-1.23%1 Month Performance-25.28%-6.11%11.46%3.36%1 Year Performance-13.25%0.26%30.49%16.59% RxSight Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RXSTRxSight2.9587 of 5 stars$33.66-11.9%$59.00+75.3%-11.8%$1.36B$128.29M-40.55220Analyst DowngradeGap DownHigh Trading VolumeINSPInspire Medical Systems4.6549 of 5 stars$188.20+0.2%$233.58+24.1%+1.7%$5.64B$755.59M176.781,011Positive NewsPRCTPROCEPT BioRobotics2.7844 of 5 stars$89.44+0.2%$97.86+9.4%+102.9%$4.67B$136.19M0.00626Positive NewsAXNXAxonics1.4257 of 5 stars$70.98+0.8%$71.00+0.0%+20.9%$3.63B$366.38M-591.45610High Trading VolumeNVCRNovoCure2.7417 of 5 stars$32.84-1.7%$32.67-0.5%+138.4%$3.55B$577.74M-23.861,453NVSTEnvista3.9067 of 5 stars$19.52+0.3%$20.65+5.8%-21.1%$3.36B$2.50B-2.5112,800Positive NewsNARIInari Medical3.3152 of 5 stars$55.46-0.2%$58.89+6.2%-11.9%$3.25B$574.50M-41.181,300Analyst ForecastInsider TradeIRTCiRhythm Technologies3.2276 of 5 stars$89.29+3.3%$107.82+20.8%-14.3%$2.79B$492.68M-17.782,000Analyst ForecastGap DownLIVNLivaNova3.6252 of 5 stars$50.11-2.7%$69.17+38.0%-4.4%$2.72B$1.24B122.622,900Analyst UpgradePositive NewsENOVEnovis3.0125 of 5 stars$46.44+0.7%$67.00+44.3%-21.5%$2.59B$2.00B-21.396,550Positive NewsWRBYWarby Parker1.5745 of 5 stars$24.31+2.9%$20.73-14.7%+99.1%$2.47B$669.77M-87.523,491Insider Trade Related Companies and Tools Related Companies Inspire Medical Systems Alternatives PROCEPT BioRobotics Alternatives Axonics Alternatives NovoCure Alternatives Envista Alternatives Inari Medical Alternatives iRhythm Technologies Alternatives LivaNova Alternatives Enovis Alternatives Warby Parker Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RXST) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RxSight, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share RxSight With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RXST Stock Alerts